Quadmedicine Director Baek Seung Ki Raises Stake to 19.62% From 19.49%

• Quadmedicine director Baek Seung Ki increased his stake to 19.62% from 19.49%.
• He bought 15,000 common shares on Oct. 20–26, 2026, bringing his holdings to 2,258,469 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quadmedicine Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261026000235), on October 26, 2026, and is solely responsible for the information contained therein.